Carson Wealth (CWM LLC)’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.04M Buy
181,899
+170,066
+1,437% +$4.37M 0.01% 808
2025
Q4
$257K Buy
11,833
+8,728
+281% +$172K ﹤0.01% 2363
2025
Q3
$47K Buy
3,105
+121
+4% +$1.5K ﹤0.01% 3587
2025
Q2
$34K Buy
2,984
+920
+45% +$9.97K ﹤0.01% 3558
2025
Q1
$21K Buy
2,064
+435
+27% +$4.7K ﹤0.01% 3645
2024
Q4
$19K Buy
1,629
+649
+66% +$7.67K ﹤0.01% 3485
2024
Q3
$11K Buy
980
+956
+3,983% +$10.9K ﹤0.01% 3750
2024
Q2
$0 Buy
24
+11
+85% +$121 ﹤0.01% 4891
2024
Q1
$0 Hold
13
﹤0.01% 4690
2023
Q4
$0 Buy
+13
New +$127 ﹤0.01% 4471

Other funds holding ROIV

Carson Wealth (CWM LLC)'s ROIV Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Roivant Sciences (ROIV) stake by 1,437% in Q1 2026, buying an estimated $4.37M and bringing the position to 181,899 shares worth $5.04M. The position accounts for 0.01% of the portfolio, ranked #808.

Carson Wealth (CWM LLC) first reported a position in ROIV in Q4 2023 and has held it in 10 quarters since. 442 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Carson Wealth (CWM LLC) held 181,899 shares of Roivant Sciences worth $5.04M as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 170,066 Roivant Sciences shares in Q1 2026, an estimated $4.37M.
  • Roivant Sciences made up 0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #808 holding.
  • Carson Wealth (CWM LLC) first reported a position in Roivant Sciences in Q4 2023 and has held it in 10 quarters since.
  • 442 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.